Slovakia, April 22 -- Evonik is investing around EUR 80 million to expand its biotechnology capabilities at its Fermas site in Slovenska ?up?a, Slovakia. The investment will add state-of-the-art downstream fermentation technology to support the contract manufacturing services of the group's drug substance business. The expansion will create approximately 50 new jobs at the site. This investment is the second major financial commitment at Fermas in recent years, following the construction of Evonik's pioneering rhamnolipids plant, initiated in 2022. Industrial biotechnology at Slovenska ?up?a has become one of Evonik's core strengths, offering excellent career opportunities for biotechnologists, laboratory technicians, engineers, and other s...